ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $5,000 | 0.0% | 1,100 | 0.0% | 0.00% | – |
| Q2 2021 | $5,000 | 0.0% | 1,100 | -83.3% | 0.00% | – |
| Q1 2021 | $5,000 | 0.0% | 6,600 | +450.0% | 0.00% | – |
| Q4 2020 | $5,000 | +25.0% | 1,200 | 0.0% | 0.00% | – |
| Q3 2020 | $4,000 | 0.0% | 1,200 | -33.3% | 0.00% | – |
| Q2 2020 | $4,000 | -20.0% | 1,800 | 0.0% | 0.00% | – |
| Q1 2020 | $5,000 | -50.0% | 1,800 | -32.0% | 0.00% | -100.0% |
| Q4 2019 | $10,000 | 0.0% | 2,649 | +29.3% | 0.00% | 0.0% |
| Q3 2019 | $10,000 | -16.7% | 2,049 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $12,000 | -14.3% | 2,049 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $14,000 | -44.0% | 2,049 | -34.9% | 0.00% | -50.0% |
| Q4 2018 | $25,000 | -65.8% | 3,149 | -18.2% | 0.00% | -60.0% |
| Q3 2018 | $73,000 | +5.8% | 3,849 | +26.2% | 0.01% | 0.0% |
| Q2 2018 | $69,000 | +331.2% | 3,049 | -63.7% | 0.01% | +150.0% |
| Q1 2018 | $16,000 | -90.5% | 8,400 | -70.3% | 0.00% | -71.4% |
| Q4 2017 | $169,000 | +634.8% | 28,300 | +106.4% | 0.01% | – |
| Q3 2017 | $23,000 | – | 13,709 | +13609.0% | 0.00% | – |
| Q1 2017 | $0 | – | 100 | 0.0% | 0.00% | – |
| Q4 2016 | $0 | -100.0% | 100 | -99.3% | 0.00% | -100.0% |
| Q3 2016 | $142,000 | -1.4% | 15,200 | +59.2% | 0.01% | 0.0% |
| Q2 2016 | $144,000 | +289.2% | 9,545 | -64.3% | 0.01% | +250.0% |
| Q1 2016 | $37,000 | – | 26,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|